Literature DB >> 4045189

Redevelopment of elevated blood pressure following adrenalectomy in rats with isolation-induced hypertension.

S M Gardiner, T Bennett.   

Abstract

We have previously shown that rats housed in individual metabolism cages develop arterial hypertension and that this can be prevented by adrenalectomy. In the present work the influence of adrenalectomy on blood pressure, heart rate and on fluid and electrolyte balance was investigated in rats with established isolation-induced hypertension. Seven days after adrenalectomy, systolic blood pressure was reduced to levels similar to those seen before the induction of hypertension; the fall in blood pressure was accompanied by tachycardia. It is likely that the reduction in blood pressure was partly due to volume depletion, since adrenalectomized rats showed reductions in fluid, sodium and potassium balance during the first week after operation. Over the following 3 weeks, blood pressure and heart rate returned to pre-operative hypertensive levels, associated with increasingly positive balances for fluid and sodium. Maintenance of elevated blood pressure in isolated rats following adrenalectomy is likely to have been aided by activation of the renin-angiotensin system, since infusion of saralasin caused profound hypotension in these circumstances, whereas it had a slight pressor effect in intact rats with isolation-induced hypertension.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045189     DOI: 10.1097/00004872-198508000-00010

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  1 in total

1.  The rapid developmental rise of somatic inhibition disengages hippocampal dynamics from self-motion.

Authors:  Robin F Dard; Erwan Leprince; Julien Denis; Shrisha Rao Balappa; Dmitrii Suchkov; Richard Boyce; Catherine Lopez; Marie Giorgi-Kurz; Tom Szwagier; Théo Dumont; Hervé Rouault; Marat Minlebaev; Agnès Baude; Rosa Cossart; Michel A Picardo
Journal:  Elife       Date:  2022-07-20       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.